Lilly’s weight-loss drug cuts diabetes risk by 94% in three-year trial, company says
Eli Lilly’s weight-loss drug cut the risk of developing type 2 diabetes by 94% in prediabetic adults who were overweight or obese after three years of weekly injections, the company...
Read more